Showing results (11-20 of 245) with videos related to
Sort By:
Pageof 25
Clinical Immunology and Immunopathology|April 1, 1996
Downregulation of interleukin-2 and apha-chain interleukin-2 receptor biosynthesis by cisplatin in human peripheral lymphocytesP P Sfikakis, V L Souliotis, N Katsilambros, et al.Clinical Immunology and Immunopathology|February 1, 1995
Characterization of in vivo mutated T cell clones from patients with systemic lupus erythematosusS Theocharis, P P Sfikakis, R N Lipnick, et al.Postgraduate Medical Journal|October 1, 1994
The association of systemic lupus erythematosus and myasthenia gravisG Vaiopoulos, P P Sfikakis, V Kapsimali, et al.Clinical and Diagnostic Laboratory Immunology|September 25, 1997
Soluble interleukin-2 receptor is a thyroid hormone-dependent early-response marker in the treatment of thyrotoxicosisR C Smallridge, G C Tsokos, K D Burman, et al.Arthritis and Rheumatism|May 1, 1995
CD28 expression on T cell subsets in vivo and CD28-mediated T cell response in vitro in patients with rheumatoid arthritisP P Sfikakis, A Zografou, V Viglis, et al.Annals of the Rheumatic Diseases|October 16, 2002
Behçet's disease: a new target for anti-tumour necrosis factor treatmentP P SfikakisCurrent Opinion in Rheumatology|September 1, 1994
Lymphocytes, cytokines, inflammation, and immune traffickingG C TsokosCurrent Opinion in Rheumatology|September 1, 1996
Lymphocytes, cytokines, inflammation, and immune traffickingG C TsokosCurrent Opinion in Rheumatology|September 1, 1995
Lymphocytes, cytokines, inflammation, and immune traffickingG C TsokosThe Journal of Rheumatology|May 1, 1996
Quinolinic acid in patients with systemic lupus erythematosus and neuropsychiatric manifestationsS A Vogelgesang, M P Heyes, S G West, et al.Pageof 25